The RECOVER IV Trial

NATerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

October 28, 2023

Primary Completion Date

May 10, 2024

Study Completion Date

December 6, 2024

Conditions
ST-segment Elevation Myocardial Infarction (STEMI)Cardiogenic Shock
Interventions
DEVICE

Impella CP®

"Subjects randomized to the Treatment Arm will undergo Impella CP placement prior to PCI. Right heart catheterization will be performed prior to or immediately after PCI.~Use of IABP will not be allowed in the Treatment Arm."

OTHER

Standard of Care

This may include inotropes and/or vasopressors. An IABP may or may not be used according to local practice and the specific condition of each individual patient. If an IABP is used, it may be placed prior to or after PCI, and its timing of explant is left to the discretion of the Investigator.

Trial Locations (7)

87102

New Mexico Heart Institute, Albuquerque

Unknown

Rigshospitalet Copenhagen, Copenhagen

University Hospital Düsseldorf, Düsseldorf

Universitatsklinikum Schleswig Holstein, Kiel

Krankenhaus der Barmherzigen Brüder Trier, Trier

Inselspital Bern, Bern

01307

Herzzentrum Dresden, Dresden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abiomed Inc.

INDUSTRY

NCT05506449 - The RECOVER IV Trial | Biotech Hunter | Biotech Hunter